×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Pfizer Limited | 6832.4 | 1418.4 | 6450.3 | 31.01 | 22,558 | 147.0 |
| AstraZeneca Pharma India Limited | 6167.0 | 325.9 | 6115.7 | 13.04 | 22029 | 104.0 |
| Wockhardt Limited | 9130.0 | 610.0 | 8880.0 | 3.61 | 21717 | 426.0 |
Pfizer Ltd.,, with Security Code 500680, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 546.6 | 562.9 | 588.6 | 538.0 | 591.9 | 603.1 | 642.3 | 645.0 |
| Expenses | 357.2 | 385.4 | 399.3 | 392.0 | 364.4 | 393.0 | 412.4 | 416.8 |
| Operating Profit | 189.4 | 177.5 | 189.3 | 146.0 | 227.5 | 210.0 | 229.9 | 228.2 |
| OPM % | 34.65% | 31.53% | 32.15% | 27.14% | 38.43% | 34.83% | 35.8% | 35.38% |
| Other Income | 75.1 | 41.8 | 43.1 | 42.8 | 217.4 | 67.2 | 41.9 | -20.0 |
| Interest | 7.0 | 2.1 | 2.1 | 1.5 | 2.7 | 3.3 | 2.1 | 2.0 |
| Depreciation | 13.8 | 14.6 | 15.0 | 14.8 | 16.4 | 14.4 | 14.3 | 14.3 |
| Profit before tax | 243.9 | 202.6 | 215.2 | 172.4 | 253.0 | 259.5 | 255.4 | 250.2 |
| Tax % | -26.7% | 25.6% | 26.4% | 26% | -22.3% | 26.1% | -26% | 26.1% |
| Net Profit | 178.9 | 150.7 | 158.4 | 127.6 | 330.9 | 191.8 | 189.0 | 141.8 |
| EPS in Rs | 22.33 | 32.94 | 0 | 27.89 | 0 | 41.91 | 0 | 31.01 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 1% |
| 3 Years: | -4% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 5% |
| 3 Years: | 2% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| 1 Year: | 12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| 1 Year: | 12% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|